Mary Dillhoff
Appearances
- DateMay 9, 2023BACKGROUND: The majority of HCC patients within Milan criteria, compete with cirrhosis patients with high MELD for liver transplantation based on an exceptional score which is the calculated MELD at registration, 28 after six months of waiting, 31 after 1 year and thereafter capped at 34 after one…
Presenter
Speakers
OHIO STATE UNIVERSITYThe Ohio State Wexner Medical Center - DateMay 9, 2023BACKGROUND: To address the persistent ethnoracial and socioeconomic disparities in access to quality surgical cancer care, it is imperative to rigorously understand the role of clinician-level factors including clinician-to-clinician connectedness…
Presenter
Speakers
OHIO STATE UNIVERSITYThe Ohio State Wexner Medical Center - DateMay 9, 2023BACKGROUND: To address the persistent ethnoracial and socioeconomic disparities in access to quality surgical cancer care, it is imperative to rigorously understand the role of clinician-level factors including clinician-to-clinician connectedness…
Presenter
Speakers
OHIO STATE UNIVERSITYThe Ohio State Wexner Medical Center - DateMay 20, 2024INTRODUCTION: Preoperative cholangitis (PC) is an important risk factor for postoperative morbidity among patients undergoing pancreatic surgery. We sought to characterize the impact of PC on surgical outcomes and healthcare costs…
Presenter
Speakers
- DateMay 21, 2024Objectives: Neoadjuvant therapy (NT) is increasingly utilized prior to surgery for most gastrointestinal (GI) and hepatopancreatobiliary (HPB) malignancies. However, chemotherapy and radiation therapy can cause significant symptoms and a high incidence of adverse events…
Presenter
Speakers
The Ohio State Wexner Medical CenterOHIO STATE UNIVERSITY